Welcome, this website is intended for international healthcare professionals with an interest in the treatment of Advanced Prostate Cancer. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Axel Merseburger MD, PhD

Prof Axel S. Merseburger is currently Chairman of the Clinic of Urology at University Hospital Schleswig-Holstein in Lübeck, Germany, having previously served as Vice Chairman of the Department of Urologic Oncology and Director of the Urologic Oncology Programme at Hannover Medical School, Germany.
Professor Merseburger obtained his medical degree from Hannover Medical School in 2002 following a 1-year academic research programme in Washington D.C., USA, where he finished his M.D. thesis. He completed a residency in surgery and urology at the Eberhard Karls University in Tübingen, Germany, and was a Research Fellow at the Miller School of Medicine, Miami, USA, in 2006. Professor Merseburger accepted a position as a staff member in Hannover in 2008 and was promoted to Associate Professor in 2009 and full Professor in 2012.
Professor Merseburger is board certified in urology and is a member of numerous national and international urological and oncological associations, as well as serving as a reviewer and member of the editorial board for many journals, Professor Merseburger is Associate Editor of the World Journal of Urology. Furthermore, he is a member of the European Association of Urology (EAU) Guideline Group for Renal Cancer and Chairman of the EAU Guideline Group for Lasers and Technologies. Professor Merseburger has won multiple awards, stipends and prizes for his molecular and clinical research and has published more than 150 papers in peer-reviewed journals. His main area of interest is urological oncology. Professor Merseburger’s key areas of interest are renal cell carcinoma, prostate cancer and transitional cell carcinoma, with special attention given to novel markers and prognostic factors. He is a principal investigator in German Phase II and III trials.

The Role of the Editor

Professor Axel Merseburger was appointed as Editor of the Advance Prostate Cancer Resource Centre on the recommendation of the EAU Executive Committee. He selects journal articles that have been previously peer-reviewed and accepted for publication in European Urology and other urology journals on Advance Prostate Cancer and related topics, building a comprehensive collection of peer-reviewed content in this area.

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.
The journal articles and other material published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor.

Follow on Twitter @kumi2804

Share

E-Alert

Register to be notified when new content is published. Only your name, country and email address needed.

Subscribe »

Latest webcast

ESMO 2016 Symposium webcast

Individualizing treatment in
metastatic prostate cancer: there
is no “one-size-fits-all” approach

EAU 2016 Scientific Programme and Sessions

View the Scientific Programme and Sessions of the 2016 EAU Annual Congress, Munich, Germany.

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.
The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views

Search this site

Search form